Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Praxis Precision Medicines (PRAX) Return on Equity: 2022-2025

Historic Return on Equity for Praxis Precision Medicines (PRAX) over the last 3 years, with Sep 2025 value amounting to -0.78%.

  • Praxis Precision Medicines' Return on Equity fell 37.00% to -0.78% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.78%, marking a year-over-year decrease of 37.00%. This contributed to the annual value of -0.78% for FY2024, which is 96.00% up from last year.
  • Per Praxis Precision Medicines' latest filing, its Return on Equity stood at -0.78% for Q3 2025, which was down 21.74% from -0.64% recorded in Q2 2025.
  • Praxis Precision Medicines' 5-year Return on Equity high stood at -0.41% for Q2 2024, and its period low was -2.62% during Q1 2023.
  • Over the past 3 years, Praxis Precision Medicines' median Return on Equity value was -0.78% (recorded in 2025), while the average stood at -1.06%.
  • As far as peak fluctuations go, Praxis Precision Medicines' Return on Equity skyrocketed by 175bps in 2024, and later plummeted by 37bps in 2025.
  • Praxis Precision Medicines' Return on Equity (Quarterly) stood at -2.37% in 2022, then spiked by 75bps to -1.62% in 2023, then surged by 113bps to -0.48% in 2024, then slumped by 37bps to -0.78% in 2025.
  • Its Return on Equity was -0.78% in Q3 2025, compared to -0.64% in Q2 2025 and -0.53% in Q1 2025.